Shopping Cart
Remove All
Your shopping cart is currently empty
MT1, a bivalent chemical probe targeting BET bromodomains, demonstrates an IC50 value of 0.789 nM for BRD4(1).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | $871 | Backorder | Backorder |
| Description | MT1, a bivalent chemical probe targeting BET bromodomains, demonstrates an IC50 value of 0.789 nM for BRD4(1). |
| In vitro | MT1 (100 nM, 24 h) prominently induces apoptosis in MV4;11 cells via caspase-3 and PARP pathways, evidenced by substantial caspase-3 and PARP cleavage in Western Blot Analysis [1]. |
| In vivo | MT1, administered intraperitoneally at doses of 44.2 and 22.1 μmol/kg daily for 14 days, significantly delayed the progression of leukemia in mice (Mus musculus) in comparison to the control, JQ1. Additionally, MT1 demonstrated a terminal half-life (t 1/2) of 2.70 hours in mice. In the context of leukemia xenograft models, this regimen markedly reduced the leukemic burden over the study period when compared to either the vehicle or JQ1. |
| Molecular Weight | 1134.2 |
| Formula | C54H66Cl2N10O9S2 |
| Cas No. | 2060573-82-0 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.